Greenlight Capital's 13F portfolio rose to $2.33B in Q2 2025. Check out the key new stakes and major increases in the ...
This year's top 10 highest-paid GCs in Pennsylvania (ranked by total cash) included six familiar names from last year's list, ...
Investing.com -- Deutsche Bank struck a more upbeat tone on European pharmaceuticals, upgrading Alvotech to Buy from Hold while keeping its price target at $14. Shares in Alvotech rose 4.6% in U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback